Long‐Term Effects of Direct‐Acting Antivirals on Hepatitis C: Trends in Liver Disease–Related Hospitalisations in Italy

This study aimed to evaluate the effectiveness of direct-acting antivirals (DAAs) on hepatitis C virus (HCV) hospitalisation trends in Italy, the country with not only the highest burden of HCV-related disease but also the highest number of patients treated for chronic HCV infection in Europe. Incident hospital discharge records in Italy from 2012 to 2019 that included a liver cirrhosis diagnosis without mention of alcohol, hepatocellular carcinoma (HCC), HCV and liver cirrhosis without mention of alcohol and/or HCC, cirrhosis with mention of alcohol, as defined by the International Classification of Diseases (ICD-9-CM) were reviewed. An interrupted time series analysis compared the incidence of cirrhosis and HCC before and after the introduction of DAAs (Year 2015). Overall, non-alcoholic cirrhosis significantly decreased after the introduction of DAAs (β<sub>3</sub> = 0.03) and for those 40-59 years of age (β<sub>3</sub> = 0.025). HCV with cirrhosis and/or HCC significantly reduced overall for those aged 40-59 and older than 60 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.002</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.002 $$</mml:annotation></mml:semantics> </mml:math> ). HCC-related hospitalisation rates significantly decreased in patients younger than 60 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.03</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.03 $$</mml:annotation></mml:semantics> </mml:math> ). Cirrhosis-related hospitalisations with mention of alcohol did not differ during the study period before and after the year 2015 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.4</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.4 $$</mml:annotation></mml:semantics> </mml:math> ). There was a significant reduction in HCV-related hospitalisations throughout Italy after introducing DAAs.

Authors

Institutions

Publication Details

Journal
Journal of Viral Hepatitis
Published
2025-01-27
DOI
https://doi.org/10.1111/jvh.14061
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐Term Effects of Direct‐Acting Antivirals on Hepatitis C: Trends in Liver Disease–Related Hospitalisations in Italy

Andrea Marcellusi, Claudia Simonelli, Paolo Sciattella, Stefano Rosato et al.
Journal of Viral Hepatitis
Hepatitis C virus research
article

Long‐Term Effects of Direct‐Acting Antivirals on Hepatitis C: Trends in Liver Disease–Related Hospitalisations in Italy

Andrea Marcellusi, Claudia Simonelli, Paolo Sciattella, Stefano Rosato, Loreta A. Kondili, Francesco Saverio Mennini
article en

Abstract

This study aimed to evaluate the effectiveness of direct-acting antivirals (DAAs) on hepatitis C virus (HCV) hospitalisation trends in Italy, the country with not only the highest burden of HCV-related disease but also the highest number of patients treated for chronic HCV infection in Europe. Incident hospital discharge records in Italy from 2012 to 2019 that included a liver cirrhosis diagnosis without mention of alcohol, hepatocellular carcinoma (HCC), HCV and liver cirrhosis without mention of alcohol and/or HCC, cirrhosis with mention of alcohol, as defined by the International Classification of Diseases (ICD-9-CM) were reviewed. An interrupted time series analysis compared the incidence of cirrhosis and HCC before and after the introduction of DAAs (Year 2015). Overall, non-alcoholic cirrhosis significantly decreased after the introduction of DAAs (β<sub>3</sub> = 0.03) and for those 40-59 years of age (β<sub>3</sub> = 0.025). HCV with cirrhosis and/or HCC significantly reduced overall for those aged 40-59 and older than 60 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.002</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.002 $$</mml:annotation></mml:semantics> </mml:math> ). HCC-related hospitalisation rates significantly decreased in patients younger than 60 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.03</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.03 $$</mml:annotation></mml:semantics> </mml:math> ). Cirrhosis-related hospitalisations with mention of alcohol did not differ during the study period before and after the year 2015 ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics> <mml:mrow><mml:msub><mml:mi>β</mml:mi> <mml:mn>3</mml:mn></mml:msub> <mml:mo>=</mml:mo> <mml:mn>0.4</mml:mn></mml:mrow> <mml:annotation>$$ {\beta}_3=0.4 $$</mml:annotation></mml:semantics> </mml:math> ). There was a significant reduction in HCV-related hospitalisations throughout Italy after introducing DAAs.

Journal of Viral HepatitisVol. 32(2)
University of Rome Tor Vergata (IT), Istituto Superiore di Sanità (IT), Ministero della Salute (IT), Saint Camillus International University of Health and Medical Sciences (IT), Albanian University (AL)
Good health and well-being
Openalex Percentile: Top 98%
Hepatitis C virus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.